Cel Sci CVM
NYSE CVM
$1.62 +0.01 (+0.62%)
As of: Oct 23, 2026 · 3:55 PM EDT

Cel Sci (CVM) Return on Sales [ROS] (2010 - 2023)

Updated

Cel Sci (CVM) recorded Return on Sales [ROS] of -27366.26% in fiscal Q3 2017 (quarter ended Jun 30, 2017), down 22822.20 percentage points from -4544.06% a year earlier.

Analysis

Cel Sci (CVM) Return on Sales [ROS] (2010 - 2023) Analysis & Trends

On a TTM basis, Cel Sci's Return on Sales [ROS] came in at -9481.25% as of Jun 30, 2017.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS (Qtr)
1 Eli Lilly 1,137.66 Bn 1,106.24 Bn 19.71 Bn 51.16%
2 Johnson & Johnson 636.13 Bn 556.00 Bn 17.30 Bn 24.35%
3 AbbVie 505.28 Bn 478.39 Bn 12.70 Bn 37.86%
4 Merck 358.10 Bn 312.48 Bn 12.21 Bn -3.52%
5 Novartis Ag 292.59 Bn 256.58 Bn 11.24 Bn 32.97%
6 Astrazeneca 265.81 Bn 239.50 Bn 12.86 Bn 20.57%
7 Amgen 237.53 Bn 192.93 Bn 7.24 Bn 34.95%
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn -133.21%
9 Pfizer 171.17 Bn 117.82 Bn 10.94 Bn 28.37%
10 Cel Sci 2.91 Mn -22.74 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2023 -16,185.01%
Mar 31, 2023 -5,140.26%
Sep 30, 2022 -2,360.86%
Mar 31, 2021 -3,272.67%
Jun 30, 2017 -27,366.26%
Jun 30, 2016 -4,544.06%
Jun 30, 2015 -91,484.84%
Mar 31, 2015 -38,283.66%
Jun 30, 2011 -6,260.41%
Jun 30, 2010 -10,984.01%
API Access

Cel Sci Return on Sales [ROS] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=CVM&period=max&api_key=YOUR_API_KEY